Incidence of abacavir hypersensitivity reactions in EuroSIDA

Wendy Bannister(The Royal Free Hospital), Ole Kirk(University of Copenhagen), Nina Friis‐Møller(University of Copenhagen), Dénes Bánhegyi(Unified Szent István and Szent László Hospital), Antonio Chiesi(Istituto Superiore di Sanità), Amanda Mocroft(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Jan van Lunzen(Universidade Federal de São Paulo), Panagiotis Gargalianos, Jean-Paul Viard(Hôpital Necker-Enfants Malades)
Antiviral Therapy
July 1, 2008
10.1177/135965350801300508
Cited by 17

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987